UBV
United Bank (Virginia) Portfolio holdings
AUM
$835M
1-Year Return
14.61%
This Quarter Return
+9.44%
1 Year Return
+14.61%
3 Year Return
+55.61%
5 Year Return
+104.58%
10 Year Return
+207.91%
AUM
$859M
AUM Growth
+$53.4M
(+6.6%)
Cap. Flow
-$15.8M
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
47.23%
Holding
150
New
8
Increased
37
Reduced
50
Closed
8
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$27M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$1.64M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.64M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$1.41M |
| 5 |
United Parcel Service
UPS
|
+$460K |
Top Sells
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$24M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$20.7M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$718K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$626K |
| 5 |
United Bankshares
UBSI
|
+$594K |
Sector Composition
| 1 | Industrials | 23.55% |
| 2 | Technology | 15.89% |
| 3 | Financials | 9.82% |
| 4 | Healthcare | 9.45% |
| 5 | Energy | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Qualcomm
QCOM
$175B
| $240K | 0.03% |
1,411
+217
| +18% | +$36.9K |
|
127
Nike
NKE
$108B
| $235K | 0.03% |
2,656
-1,000
| -27% | -$88.4K |
|
128
Wells Fargo
WFC
$261B
| $226K | 0.03% |
4,000
| – | – |
|
129
Intuit
INTU
$180B
| $214K | 0.02% |
344
-53
| -13% | -$32.9K |
|
130
Advanced Micro Devices
AMD
$257B
| $211K | 0.02% |
1,285
-204
| -14% | -$33.5K |
|
131
Morgan Stanley
MS
$250B
| $208K | 0.02% |
+2,000
| New | +$208K |
|
132
Accenture
ACN
$149B
| $208K | 0.02% |
+588
| New | +$208K |
|
133
iShares Russell 1000 ETF
IWB
$44.5B
| $204K | 0.02% |
+650
| New | +$204K |
|
134
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $201K | 0.02% |
+1,000
| New | +$201K |
|
135
Trevi Therapeutics
TRVI
$1B
| $104K | 0.01% |
31,200
| – | – |
|
136
Cardiff Oncology
CRDF
$136M
| $48.1K | 0.01% |
18,000
| – | – |
|
137
Lineage Cell Therapeutics
LCTX
$306M
| $47.1K | 0.01% |
52,000
| – | – |
|
|
AUTL
138
Autolus Therapeutics
AUTL
$367M
| $39.4K | ﹤0.01% |
10,850
-650
| -6% | -$2.36K |
|
139
BioAtla
BCAB
$45.5M
| $22.9K | ﹤0.01% |
13,000
| – | – |
|
|
KZIA
140
Kazia Therapeutics
KZIA
$8.94M
| $18.9K | ﹤0.01% |
+880
| New | +$18.9K |
|
141
Talphera
TLPH
$19.3M
| $12.7K | ﹤0.01% |
14,800
| – | – |
|
142
Vor Biopharma
VOR
$220M
| $10.7K | ﹤0.01% |
15,300
| – | – |
|
143
Adobe
ADBE
$148B
| – | – |
-567
| Closed | -$315K |
|
144
Intel
INTC
$112B
| – | – |
-7,067
| Closed | -$219K |
|
145
iShares Russell 3000 ETF
IWV
$16.9B
| – | – |
-1,770
| Closed | -$546K |
|
146
Linde
LIN
$226B
| – | – |
-507
| Closed | -$222K |
|
147
Micron Technology
MU
$176B
| – | – |
-1,625
| Closed | -$214K |
|
148
Union Pacific
UNP
$127B
| – | – |
-1,360
| Closed | -$308K |
|
149
Vanguard Dividend Appreciation ETF
VIG
$97.5B
| – | – |
-1,235
| Closed | -$225K |
|